ATI RN
CNS Drugs Pharmacology PDF Questions
Question 1 of 5
A 38-year-old man with chronic anxiety and agitation is currently being treated with a long-acting benzodiazepine. He is having challenges with sleep and is referred to a sleep center for a 24-h sleep study to further ascertain his difficulties. Which of the following is the most likely abnormality to be noted on this study?
Correct Answer: B
Rationale: The correct answer is B) Hourly awakening from sleep. In this case, the patient is using a long-acting benzodiazepine for anxiety and agitation, which can lead to sleep disturbances such as frequent awakenings. Benzodiazepines, although they may aid in sleep initiation, can disrupt the architecture of sleep by reducing slow-wave sleep and increasing awakenings during the night. Option A) Calming effect during sleep induction is incorrect because benzodiazepines may induce initial sedation but can disrupt sleep architecture later in the night. Option C) Hypnotic effect with dreams is incorrect as benzodiazepines are not typically associated with vivid dreams but rather with disturbances in sleep continuity. Option D) Improved slow-wave sleep is incorrect because benzodiazepines are known to decrease slow-wave sleep. In an educational context, understanding the effects of CNS drugs on sleep architecture is crucial for healthcare professionals to effectively manage patients with sleep disturbances related to medication use. This question highlights the importance of recognizing the potential adverse effects of benzodiazepines on sleep patterns and the need for further evaluation in patients experiencing sleep disturbances.
Question 2 of 5
A 19-year-old man with a significant seizure history has various seizures including partial onset seizures, myoclonic seizures, and, occasionally, primary generalized tonic-clonic seizures. His physician prescribed levetiracetam. This agent likely works on which of the following structures?
Correct Answer: C
Rationale: Levetiracetam is an antiepileptic drug commonly used to treat various types of seizures. The correct answer is C) Synaptic vesicle protein. Levetiracetam exerts its antiepileptic effects by binding to synaptic vesicle protein 2A (SV2A), which is involved in the regulation of neurotransmitter release. By binding to SV2A, levetiracetam modulates neurotransmitter release, thus reducing abnormal neuronal activity and preventing seizures. Option A) Calcium channel modulation is incorrect because levetiracetam does not directly affect calcium channels. Option B) Collapsing response mediator protein-2 is incorrect as this protein is not targeted by levetiracetam for its antiepileptic effects. Option D) Sodium channels is also incorrect as levetiracetam does not primarily act on sodium channels like other antiepileptic drugs such as carbamazepine or phenytoin. In an educational context, understanding the mechanism of action of antiepileptic drugs like levetiracetam is crucial for healthcare professionals to make informed decisions when treating patients with seizure disorders. Knowledge of how different drugs target specific molecular pathways can help optimize treatment strategies and improve patient outcomes.
Question 3 of 5
A 26-year-old man complains of tremors, tachycardia, and diaphoresis when speaking in public. He has started a new job that requires him to give frequent presentations to large audiences and is worried he would not be able to work effectively. His physician prescribes propranolol. How will propranolol help with this patient's anxiety?
Correct Answer: E
Rationale: The correct answer is not provided in the options given. The most appropriate answer in this case should be: E) Propranolol is a beta-blocker that can help alleviate the physical symptoms of anxiety such as tremors, tachycardia, and diaphoresis. By blocking beta-adrenergic receptors, propranolol reduces the effects of adrenaline, which is responsible for these symptoms. This allows the individual to feel more physically calm and in control, which can be beneficial for situations like public speaking where anxiety symptoms can be disruptive. Let's analyze why the other options are incorrect: A) CNS sedation: Propranolol does not exert its anxiolytic effects through CNS sedation. It works peripherally by blocking beta receptors. B) CNS stimulation: This is incorrect as propranolol is not a CNS stimulant. It acts peripherally on beta receptors. C) Patients with anxiety usually have comorbid heart disease: This statement is not universally true and is not directly related to the mechanism of action of propranolol in managing anxiety. D) Propranolol is not used to treat anxiety: This is incorrect as propranolol is commonly used off-label to manage performance anxiety and situational anxiety by alleviating physical symptoms. Educational context: It is important for healthcare professionals to understand the pharmacological mechanisms of drugs used in the treatment of anxiety disorders. Propranolol's role in managing performance anxiety can be a valuable addition to the treatment options available, especially for individuals who primarily experience physical symptoms of anxiety. Understanding how medications work can help clinicians make informed decisions when selecting appropriate treatments for patients.
Question 4 of 5
Regarding differences between the sympathetic and parasympathetic nervous systems in a healthy 29-year-old graduate student athlete, which of the following is a feature of the sympathetic nervous system?
Correct Answer: D
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.
Question 5 of 5
Which of the following changes occur at the neurotransmitter/synaptic space when an excitatory postsynaptic potential is generated?
Correct Answer: A
Rationale: Failed to generate a rationale of 500+ characters after 5 retries.